Adrian R. Krainer sold $287K of Stoke Therapeutics (STOK)

Executed Mar 2, disclosed Mar 4, 2 days later.

Value, as filed

$287K

7,229 sh × $39.66

Executed

Mar 2

the trade date, as filed

Disclosed

Mar 4

2 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Adrian R. Krainer Director profile →

Adrian R. Krainer (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Stoke Therapeutics, Inc. (STOK). The largest single filing was $1.3M of STOK (33,243 sh × $39.74, as filed), executed Mar 10.

The name

STOK

Stoke Therapeutics, Inc. STOK · Healthcare · 35 filings in 24 months ticker →

Healthcare · Stoke Therapeutics, Inc. engages in the development of treatments for severe genetic diseases by upregulating protein expression

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Adrian R. Krainer in STOK

STOKSALE Stoke Therapeutics, Inc. $1.3M
33,243 sh × $39.74
Exec Mar 10
Filed Mar 12 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $1.2M
40,472 sh × $29.72
Exec Nov 24 2025
Filed Nov 26 2025 · 5:30 PM ET STOKSALE Stoke Therapeutics, Inc. $1.1M
40,472 sh across 2 lots
Exec Nov 14 2025
Filed Nov 18 2025 · 5:30 PM ET